Picture of Gritstone bio logo

GRTSQ — Gritstone bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Gritstone Announces Updated Overall Survival Results In Advanced Colorectal Cancer Patients From Phase 1/2 Study Of Granite And Trial In Progress Poster At ASCO

May 31 (Reuters) - Gritstone bio Inc  GRTS.O :
    * GRITSTONE ANNOUNCES UPDATED OVERALL SURVIVAL RESULTS IN
ADVANCED
COLORECTAL CANCER PATIENTS FROM PHASE 1/2 STUDY OF GRANITE AND
TRIAL IN PROGRESS POSTER AT ASCO
    * GRITSTONE BIO- OS FOR PATIENTS WITH MSS-CRC WHO HAD TWO
PRIOR
LINES OF THERAPY AND MOLECULAR RESPONSE AS PRESENTED AT ESMO
2021, TO EXCEED 18 MONTHS

Source text for Eikon:  ID:nGNXbc9t0D 
Further company coverage:  GRTS.O

Recent news on Gritstone bio

See all news